Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
22.65B | 21.48B | 21.93B | 23.98B | 18.63B |
Gross Profit | ||||
4.07B | 5.75B | 5.00B | 4.86B | 4.06B |
EBIT | ||||
4.06B | 2.49B | 987.75M | 3.59B | 5.12B |
EBITDA | ||||
5.17B | 3.96B | 2.55B | 6.77B | 6.61B |
Net Income Common Stockholders | ||||
2.81B | 2.26B | 1.11B | 3.86B | 3.90B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
4.16B | 5.65B | 2.68B | 3.49B | 3.22B |
Total Assets | ||||
57.38B | 55.82B | 49.70B | 49.54B | 46.78B |
Total Debt | ||||
17.57B | 15.23B | 12.66B | 11.99B | 10.04B |
Net Debt | ||||
13.41B | 9.60B | 9.98B | 8.52B | 6.82B |
Total Liabilities | ||||
31.75B | 31.63B | 28.57B | 27.36B | 26.53B |
Stockholders Equity | ||||
25.67B | 23.89B | 20.82B | 21.84B | 19.96B |
Cash Flow | Free Cash Flow | |||
3.26B | 3.30B | 2.95B | 3.04B | 3.77B |
Operating Cash Flow | ||||
3.39B | 3.52B | 3.90B | 3.39B | 4.02B |
Investing Cash Flow | ||||
-5.74B | -3.14B | -2.77B | 31.91M | -1.67B |
Financing Cash Flow | ||||
803.86M | 2.70B | -1.92B | -2.88B | -1.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $94.77B | 21.46 | 9.10% | 3.41% | 4.46% | 54.09% | |
77 Outperform | $100.85B | 23.02 | 13.61% | 3.13% | 5.83% | 10.23% | |
77 Outperform | $5.23B | 2.29 | 9.47% | 3.02% | -4.45% | ― | |
74 Outperform | $39.05B | 21.10 | 8.44% | 3.02% | 4.23% | -27.02% | |
73 Outperform | $58.35B | 19.57 | 11.37% | 3.31% | 2.76% | 31.53% | |
72 Outperform | $145.82B | 21.02 | 14.24% | 2.98% | 26.91% | -6.43% | |
65 Neutral | $12.17B | 16.15 | 5.32% | 4.37% | 5.50% | -9.06% |